Kexing Biopharm’s Innovative Drug GB19 Received Approval From FDA To Conduct Clinical Trials
Recently, GB19 Injection, independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm, has officially received...
